Fathom Therapeutics
Uses quantum chemistry and AI to design novel drug molecules
$47MSeries A
Role not disclosedAV
Alexandria Venture Investments
Activity from announced rounds
Activity in this selectionApr 30, 2026 · AI · Apr 1, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $87M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionAlloy Therapeutics
Drug discovery platforms and integrated development services for biotechnology and pharmaceutical partners.
$40MSeries E
Role not disclosed